The importance of biomarkers in determining the prognosis of patients requiring intensive care hospitalization due to COVID-19 infection COVID-19 mortality and biomarkers
Article Sidebar
Main Article Content
Abstract
Objective: This study aims to investigate the effect of biomarkers such as CRP, ferritin, troponin, lymphopenia, and D-dimer in predicting disease severity and clinical outcome. Identifying an effective and predictive biomarker will help to evaluate patients' risk and improve overall clinical management of patients with COVID-19
Material and Methods: In this retrospective cohort study, 1458 patients who were taken to intensive care follow-up due to COVID-19 across the province of Bursa were evaluated. Age, gender, and laboratory data such as ferritin, D-dimer, White Blood Cell (WBC), C-reactive protein, troponin values, chronic diseases, length of stay in the intensive care unit, and mortality were recorded. The relation of these variables with mortality was analyzed.
Results: There was no significant difference between the groups regarding age and length of stay in the intensive care unit (p=379, p=0.094). There was a statistically significant difference between the groups for ferritin, CRP, D-dimer, troponin, and WBC variables (p<0.001). In the ROC analysis, it was seen that the sensitivity value for ferritin was 86.08%, the specificity value was 85.23%, and the AUC: 0.902 had a high level of diagnostic value.
Conclusion: An increase in acute phase reactants was associated with mortality in patients followed up for COVID-19. This may be related to the increased cytokine response triggered by the disease.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2022-09-27
Published 2022-09-27
References
Wu Z, McGoogan JM: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama 2020, 323(13):1239-1242.
https://news.google.com/COVID19/map?hl=tr&mid=%2Fm%2F02j71&gl=TR&ceid=TR%3Atr access date:09.08.2022.
https://COVID19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html access date:09.032.2022.
https://apps.who.int/iris/handle/10665/330893 access date: 09.08.2022.
Kocayiğit, H., et al., Characteristics and outcomes of critically ill patients with COVID-19 in Sakarya, Turkey: asingle centre cohort study. Turkish journal of medical sciences, 2021. 51(2): p. 440-447.
Wu, Z. and J.M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. jama, 2020. 323(13): p. 1239-1242.
https://news.google.com/COVID19/map?hl=tr&mid=%2Fm%2F02j71&gl=TR&ceid=TR%3Atr access date:09.08.2022.
https://COVID19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html access date:09.032.2022.
https://apps.who.int/iris/handle/10665/330893 access date: 09.08.2022.
Kocayiğit, H., et al., Characteristics and outcomes of critically ill patients with COVID-19 in Sakarya, Turkey: asingle centre cohort study. Turkish journal of medical sciences, 2021. 51(2): p. 440-447.
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669. PMID: 22797452.
Khwaja, A., KDIGO clinical practice guidelines for acute kidney injury. Nephron Clinical Practice, 2012. 120(4): p. c179-c184.
Livingston, E. and K. Bucher, Coronavirus Disease 2019 (COVID-19) in Italy. JAMA, 2020. 323(14): p. 1335-1335.
El Aidaoui, K., et al., Predictors of severity in COVID-19 patients in Casablanca, Morocco. Cureus, 2020. 12(9).
Garcia, P.D.W., et al., Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine, 2020. 25: p. 100449.
Guan, W.-j., et al., Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine, 2020. 382(18): p. 1708-1720.
Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 2020. 395(10223): p. 497-506.
Zhou, F., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 2020. 395(10229): p. 1054-1062.
Wang, B., et al., Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (albany NY), 2020. 12(7): p. 6049.
Onder, G., G. Rezza, and S. Brusaferro, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama, 2020. 323(18): p. 1775-1776.
Griffith, D.M., et al., Men and COVID-19: a biopsychosocial approach to understanding sex differences in mortality and recommendations for practice and policy interventions. Preventing chronic disease, 2020. 17: p. E63.
Regitz-Zagrosek, V. and G. Kararigas, Mechanistic pathways of sex differences in cardiovascular disease. Physiological reviews, 2017. 97(1): p. 1-37.
McIntosh, K., M. Hirsch, and A. Bloom, Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. Lancet. Infect. Dis, 2020. 1: p. 2019-2020.
Shereen, M.A., et al., COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses. Journal of advanced research, 2020. 24: p. 91-98.
Vetter, P., et al., Clinical features of COVID-19. 2020, British Medical Journal Publishing Group.
Bolondi, G., et al., Iron metabolism and lymphocyte characterisation during COVID-19 infection in ICU patients: an observational cohort study. World Journal of Emergency Surgery, 2020. 15(1): p. 1-8.
Kernan, K.F. and J.A. Carcillo, Hyperferritinemia and inflammation. International immunology, 2017. 29(9): p. 401-409.
Giemza-Stokłosa, J., M.A. Islam, and P.J. Kotyla, Hyperferritinaemia: an iron sword of autoimmunity. Current pharmaceutical design, 2019. 25(27): p. 2909-2918.
Cassat, J.E. and E.P. Skaar, Iron in infection and immunity. Cell host & microbe, 2013. 13(5): p. 509-519.
Drakesmith, H. and A. Prentice, Viral infection and iron metabolism. Nature Reviews Microbiology, 2008. 6(7): p. 541-552.
Drakesmith, H. and A.M. Prentice, Hepcidin and the iron-infection axis. science, 2012. 338(6108): p. 768-772.
Dhondt, N., et al., Childhood adversity and adolescent psychopathology: evidence for mediation in a national longitudinal cohort study. The British Journal of Psychiatry, 2019. 215(3): p. 559-564.
Litton, E. and J. Lim, Iron metabolism: an emerging therapeutic target in critical illness. Annual Update in Intensive Care and Emergency Medicine 2019, 2019: p. 573-584.
Fan, S.-L., et al., Diagnosing sepsis–the role of laboratory medicine. Clinica chimica acta, 2016. 460: p. 203-210.
Gabay, C. and I. Kushner, Acute-phase proteins and other systemic responses to inflammation. New England journal of medicine, 1999. 340(6): p. 448-454.
Ruan, Q., et al., Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine, 2020. 46(5): p. 846-848.
Jin, Y., et al., Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 2020. 12(4): p. 372.
Teijaro, J.R. Cytokine storms in infectious diseases. in Seminars in immunopathology. 2017. Springer.
Chen, T., et al., Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj, 2020. 368.
Yuki, K., M. Fujiogi, and S. Koutsogiannaki, COVID-19 pathophysiology: A review. Clinical immunology, 2020. 215: p. 108427.
Velavan, T.P. and C.G. Meyer, Mild versus severe COVID-19: laboratory markers. International Journal of Infectious Diseases, 2020. 95: p. 304-307.
Henry, B.M., COVID-19, ECMO, and lymphopenia: a word of caution. The Lancet Respiratory Medicine, 2020. 8(4): p. e24.
Organization, W.H., Clinical management of severe acute respiratory infection when COVID-19 is suspected (v1. 2). 2020: 1-21.
Qin, C., et al., Desregulación de la respuesta inmune en pacientes con coronavirus 2019 (COVID-19) en Wuhan, China. Enfermedades infecciosas Infecciosas cClínicas, 2020. 71(15): p. 762-768.
Thirumalaisamy, P. and C. Meyer, Mild versus severe COVID-19: Laborytorma markers. Int. J. Infect. Dis, 2020. 95: p. 304-307.
Wang, W.-K., et al., Temporal relationship of viral load, ribavirin, interleukin (IL)—6, IL-8, and clinical progression in patients with severe acute respiratory syndrome. Clinical infectious diseases, 2004. 39(7): p. 1071-1075.
Asghar, M.S., et al., Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus, 2020. 12(8).
Rodelo, J.R., et al., D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. The American journal of emergency medicine, 2012. 30(9): p. 1991-1999.
Bhutta, Z.A., et al., COVID-19 risks and response in South Asia. 2020, British Medical Journal Publishing Group.
Tang, N., et al., Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis, 2020. 18(4): p. 844-847.
Hu, H., et al., Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin (published online ahead of print March 16, 2020). Eur Heart J.
Shi, S., et al., Cardiac injury in patients with corona virus disease 2019. JAMA Cardiol, 2020. 5(7): p. 802-810.
Çelik, D. and Ş. Köse, Erişkinlerde COVID-19: klinik bulgular. Tepecik Eğit. ve Araşt. Hast. Dergisi, 2020. 30(2): p. 43-48.
Bai, Y., et al., Presumed asymptomatic carrier transmission of COVID-19. Jama, 2020. 323(14): p. 1406-1407.
Kochi, A.N., et al., Cardiac and arrhythmic complications in patients with COVID‐19. Journal of cardiovascular electrophysiology, 2020. 31(5): p. 1003-1008.
Bansal, M., Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(3): p. 247-250.
Lippi, G., C.J. Lavie, and F. Sanchis-Gomar, Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Progress in cardiovascular diseases, 2020. 63(3): p. 390.
Wang, D., et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama, 2020. 323(11): p. 1061-1069.
Liu, W., et al., Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese medical journal, 2020. 133(09): p. 1032-1038.
Zhu, N., et al., A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine, 2020.
Bhatraju, P.K., et al., COVID-19 in critically ill patients in the Seattle region—case series. New England Journal of Medicine, 2020. 382(21): p. 2012-2022.
Schädler, D., et al., The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PloS one, 2017. 12(10): p. e0187015.
Yang, X., et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 2020. 8(5): p. 475-481.
Clark, A., et al., Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. The Lancet Global Health, 2020. 8(8): p. e1003-e1017.
Luo, X., et al., Prognostic value of C-reactive protein in patients with coronavirus 2019. Clinical Infectious Diseases, 2020. 71(16): p. 2174-2179.
Zhang, J.-j., et al., Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy, 2020. 75(7): p. 1730-1741.
Ahmed, S., et al., Evaluation of serum ferritin for prediction of severity and mortality in COVID-19-A cross sectional study. Annals of medicine and Surgery, 2021. 63: p. 102163.
Cecconi, M., et al., Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for COVID-19 infection in Lombardy, Italy. Journal of clinical medicine, 2020. 9(5): p. 1548.
Wang, F., et al., Clinical characteristics of 28 patients with diabetes and COVID-19 in Wuhan, China. Endocrine Practice, 2020. 26(6): p. 668-674.
Zheng, Z., et al., Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of infection, 2020. 81(2): p. e16-e25.
Arentz, M., et al., Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. Jama, 2020. 323(16): p. 1612-1614.
Bennouar, S., et al., Usefulness of biological markers in the early prediction of corona virus disease-2019 severity. Scandinavian Journal of Clinical and Laboratory Investigation, 2020. 80(8): p. 611-618.
Feld, J., et al., Ferritin levels in patients with COVID‐19: a poor predictor of mortality and hemophagocytic lymphohistiocytosis. International journal of laboratory hematology, 2020. 42(6): p. 773-779.
Gómez-Pastora, J., et al., Hyperferritinemia in critically ill COVID-19 patients–is ferritin the product of inflammation or a pathogenic mediator? Clinica Chimica Acta; International Journal of Clinical Chemistry, 2020. 509: p. 249.
Gülcher, S.S., et al., Elevated C-reactive protein levels at ICU discharge as a predictor of ICU outcome: a retrospective cohort study. Annals of intensive care, 2016. 6(1): p. 1-8.
Koozi, H., M. Lengquist, and A. Frigyesi, C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. Journal of critical care, 2020. 56: p. 73-79.
Henry, B.M., et al., Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM), 2020. 58(7): p. 1021-1028.
Ullah, W., et al., Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. Journal of community hospital internal medicine perspectives, 2020. 10(5): p. 402-408.
Cai, Q., et al., COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy, 2020. 75(7): p. 1742-1752.
Wan, S., et al., Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology, 2020. 92(7): p. 797-806.
Zhang, G., et al., Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. MedRxiv, 2020.
Rodriguez-Morales, A.J., et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel medicine and infectious disease, 2020. 34: p. 101623.
He, Z., et al., Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. International journal of infectious diseases, 2005. 9(6): p. 323-330.
Lippi, G. and E.J. Favaloro, D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thrombosis and haemostasis, 2020. 120(05): p. 876-878.
Sakka, M., et al., Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis. JMV-Journal de Médecine Vasculaire, 2020. 45(5): p. 268-274.
Tang, N., et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis, 2020. 18(5): p. 1094-1099.
Zhang, L., et al., D‐dimer levels on admission to predict in‐hospital mortality in patients with COVID‐19. Journal of thrombosis and haemostasis, 2020. 18(6): p. 1324-1329.
Panigada, M., et al., Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. Journal of thrombosis and haemostasis, 2020. 18(7): p. 1738-1742.
Ranucci, M., et al., The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome. Journal of Thrombosis and Haemostasis, 2020. 18(7): p. 1747-1751.
Danzi, G.B., et al., Acute pulmonary embolism and COVID-19 pneumonia: a random association? European heart journal, 2020. 41(19): p. 1858-1858.
Zhang, Y., et al., Coagulopathy and antiphospholipid antibodies in patients with COVID-19. New England Journal of Medicine, 2020. 382(17): p. e38.
Cui, S., et al., Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 2020. 18(6): p. 1421-1424.
Klok, F., et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis research, 2020. 191: p. 145-147.
Wang, T., et al., Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. The Lancet Haematology, 2020. 7(5): p. e362-e363.
Wibowo, A., et al., Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression. International Journal of Infectious Diseases, 2021. 105: p. 312-318.
Lombardi, C.M., et al., Association of troponin levels with mortality in Italian patients hospitalized with coronavirus disease 2019: results of a multicenter study. JAMA cardiology, 2020. 5(11): p. 1274-1280.
McEvoy, J.W., et al., Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA cardiology, 2016. 1(5): p. 519-528.
Pattanshetty, D.J., et al., Elevated troponin predicts long-term adverse cardiovascular outcomes in hypertensive crisis: a retrospective study. Journal of hypertension, 2012. 30(12): p. 2410-2415.
Segre, C.A.W., et al., Troponin in diabetic patients with and without chronic coronary artery disease. BMC cardiovascular disorders, 2015. 15(1): p. 1-6.
Zethelius, B.r., N. Johnston, and P. Venge, Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation, 2006. 113(8): p. 1071-1078.
Shi, S., et al., Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiology, 2020. 5(7): p. 802-810.
Pranata, R., I. Huang, and S.B. Raharjo, Incidence and impact of cardiac arrhythmias in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Indian pacing and electrophysiology journal, 2020. 20(5): p. 193-198.
Pranata, R., et al., Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgraduate Medical Journal, 2020. 96(1137): p. 387-391.